068270 logo

Celltrion Inc (068270)

Celltrion, Inc., a biopharmaceutical company, engages in the development, production, and sale of development, production, and sale of medicinal products. It offers biosimilars, including Remsima for rheumatoid arthritis and inflammatory bowel disease; Truxima for non-hodgkin's lymphoma and chronic lymphocytic leukemia; Herzuma for metastatic breast and gast...

KOHealthcareBiotechnologyKorea

公司简介

股票代码
068270
ISIN代码
KR7068270008
货币
Korean Won (KRW)
IPO日期
2005-07-19

联系信息

公司地址
23, Academy-ro, Incheon, South Korea
联系电话
82 3 2850 5000
公司网站
https://www.celltrion.com
财年结束
December

财务亮点

市值
$999,999.99
毛利润(TTM)
$999,999.99
股息收益率
0.37%
资产回报率(TTM)
3.79%
EBITDA
$999,999.99
收入(TTM)
$999,999.99